Psychedelic Business Spotlight – February 25
This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon; Small Pharma advances DMT.
psilocybin
4 Signs the Psychedelics Movement Is Unstoppable
With no strong resistance manifesting to oppose the psychedelic renaissance, it appears these drugs have re-emerged from underground for a permanent place in our culture.
How Long Until Psychedelic Stocks Payoff?
Our resident Psychedelic Investor explores one of the biggest questions on minds of those investing in psychedelic stocks.
‘Altered States’: How One of Horror’s Most Psychedelic Films Altered My Life
Filmmaker Matthew Dunehoo, the director of our “Spotlight in Focus” series, reflects on a 1980 sci-fi horror movie that every psychonaut should see, and can probably relate to.
When Will Psilocybin Be Available in Oregon and What’s the Hold-Up?
The Oregon Health Authority has until December 31, 2022, to finalize the framework, paving the way for licensure in early 2023.
Cybin Partners with The Chopra Foundation to Bring Awareness to the Benefits of Psychedelic-Based Therapies
“The need for new and more effective treatments across the mental health spectrum is more urgent today than ever,” says Dr. Deepak Chopra.
Cathie Woods’ ARK Invest Conducting ‘Deep Dive’ Into Psychedelic Stocks
Cathie Wood and Ark Invest buying psychedelic stocks will be significant for the industry, as Wood holds a megaphone with which she communicates to retail growth investors.
Oregon Psilocybin Advisory Board Proposes Legalizing Just One Species of Psychedelic Fungi
“These fungi pose less potential safety risks to consumers,” says Psilocybin Advisory Board mycologist Jessie Uehling.
That Time Snoop Dogg Ate Mushrooms and Cried Backstage
“I don’t even know what got into my emotions, but I felt so good, and the crying just made me feel even better,” the Super Bowl halftime show performer says.
Maine CDC Director Opposes Bill to Legalize Therapeutic Psilocybin
One of Dr. Nirav Shah’s chief concerns with the bill is proposed “Psilocybin Service Centers,” which he fears will lean recreational instead of medical.
End of content
End of content